Noveris Health Sciences (MYCOF) Stock Price, News & Analysis
Company Description
Noveris Health Sciences (OTC Link: MYCOF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $42.7M.
MYCOF has gained 131.8% over the past year. Shares last traded at $0.7300.
This page collects what Stock Titan holds for MYCOF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Noveris Health Sciences (MYCOF) stock last closed at $0.7300. Over the past 12 months, the stock has gained 131.8%. At a market capitalization of $42.7M, MYCOF is classified as a micro-cap stock with approximately 58.5M shares outstanding.
Latest News
Noveris Health Sciences has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 4 with negative movement. Key topics include private placement, earnings, management. View all MYCOF news →
SEC Filings
Financial Highlights
Upcoming Events
Conversion eligibility
Hold period expiry
Debenture maturity
Warrant expiry
Noveris Health Sciences has 4 upcoming scheduled events. The next event, "Conversion eligibility", is scheduled for December 28, 2026 (in 117 days). 3 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the MYCOF stock price.
Short Interest History
Short interest in Noveris Health Sciences (MYCOF) currently stands at 637 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Noveris Health Sciences (MYCOF) currently stands at 1000.0 days, up 99899% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 99899% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
MYCOF Company Profile & Sector Positioning
Noveris Health Sciences (MYCOF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing MYCOF often look at related companies in the same sector, including Canaquest Medica (CANQF), Real Brands (RLBD), Indoor Harvest (INQD), Branded Legacy Inc (BLEG), and Lowell Farms (LOWLF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MYCOF's relative position within its industry.